Publications by authors named "Tamar Reshef"

Claim this Profile
T
T cell-induced mast cell activation: a role for microparticles released from activated T cells.
Irit Shefler, Pazit Salamon, Tamar Reshef, Adam Mor, Yoseph A Mekori

J Immunol· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differential antinuclear antibodies pattern.
Tamar Reshef, Yoseph A Mekori, Adam Mor

Isr Med Assoc J· February 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inflammatory biomarkers are not predictive of intermediate-term risk of ventricular tachyarrhythmias in stable CHF patients.
Yuval Konstantino, Jairo Kusniec, Tamar Reshef, Ofer David-Zadeh, Alexander Mazur

Clin Cardiol· August 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence and evaluation of B12 deficiency in patients with autoimmune thyroid disease.
Rosane Ness-Abramof, Dan A Nabriski, Lewis E Braverman, Lotan Shilo, Eliahu Weiss, Tamar Reshef

Am J Med Sci· September 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
C-reactive protein level as a predictor of transient vs. sustained anticardiolipin antibody positivity.
Orit Twito, Tamar Reshef, Martin H Ellis

Eur J Haematol· March 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD40 ligand and risk of ischemic stroke or coronary events in patients with chronic coronary heart disease.
David Tanne, Moti Haim, Uri Goldbourt, Valentina Boyko, Tamar Reshef

Int J Cardiol· March 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High prevalence of thrombophilia among young patients with myocardial infarction and few conventional risk factors.
Amit Segev, Martin H Ellis, Fani Segev, Ziva Friedman, Tamar Reshef

Int J Cardiol· February 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Monocyte chemoattractant protein-1 and recurrent cardiovascular events in patients with stable coronary heart disease.
Moti Haim, David Tanne, Valentina Boyko, Tamar Reshef, Uri Goldbourt

Clin Cardiol· January 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chlamydia pneumoniae and future risk in patients with coronary heart disease.
Moti Haim, David Tanne, Alexander Battler, Valentina Boyko, Tamar Reshef

Int J Cardiol· January 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prospective study of Chlamydia pneumoniae IgG and IgA seropositivity and risk of incident ischemic stroke.
David Tanne, Moti Haim, Valentina Boyko, Uri Goldbourt, Tamar Reshef

Cerebrovasc Dis· August 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Soluble intercellular adhesion molecule-1 and risk of future ischemic stroke: a nested case-control study from the Bezafibrate Infarction Prevention (BIP) study cohort.
David Tanne, Moti Haim, Valentina Boyko, Uri Goldbourt, Tamar Reshef

Stroke· September 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Soluble intercellular adhesion molecule-1 and long-term risk of acute coronary events in patients with chronic coronary heart disease. Data from the Bezafibrate Infarction Prevention (BIP) Study.
Moti Haim, David Tanne, Valentina Boyko, Tamar Reshef, Uri Goldbourt

J Am Coll Cardiol· April 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis